Switching HIV-1 protease inhibitor therapy: which? When? And why? [electronic resource]
Producer: 19990209Description: 194-5 p. digitalISSN:- 0003-9926
- AIDS-Related Opportunistic Infections -- mortality
- Acquired Immunodeficiency Syndrome -- complications
- Anti-HIV Agents -- administration & dosage
- Drug Administration Schedule
- HIV Protease Inhibitors -- administration & dosage
- Humans
- Indinavir -- administration & dosage
- Odds Ratio
- Ritonavir -- administration & dosage
- Saquinavir -- administration & dosage
- Spain
- Survival Analysis
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.